pembrolizumab
merck
['kidney cancer', 'keytruda']
the findings, according to the investigators, further support the use of revlimid plus keytruda as a standard-of-care first-line treatment for patients with advanced kidney cancer. #asco22 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.